Rare tumor of intestine

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

1 event
Dec 1988

Ifex: FDA approved

In combination with certain other approved antineoplastic agents, for third line chemotherapy in the treatment of germ cell testicular cancer.

FDAcompleted

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

1

Total programs

1

Open now

Patient Assistance Programs1

Ifex

Bristol-Myers Squibb Pharmaceutical Research Institute

OpenContact for detailsApply ↗

View all support programs on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Rare tumor of intestine.
Search all trials →
Search clinical trials for Rare tumor of intestine

Recent News & Research

No recent news articles indexed yet for Rare tumor of intestine.
Search PubMed for Rare tumor of intestine

Browse all Rare tumor of intestine news →

Specialist Network

Top 6 by expertise

View all Rare tumor of intestine specialists →

Quick Actions